RxDoctor Payments Data

Jennifer Hegarty, APRN

Family · Crystal River, FLNPI 1588800726

Payments from drug & device makers

$548in general payments, 2019–2025

Across 34 payments — averaging $16.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$194
  • Exact Sciences$75
  • AbbVie$66
  • Abbott$51
  • Corium, LLC$37
  • Bayer$36
  • plus $89 from 4 others

What the payments were for

  • Food & beverage$548100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$548 in reported general payments places this provider in the 55th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$10,012
Medicare patients
74
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$86,923
EliquisApixaban55$52,638
JardianceEmpagliflozin40$39,114
Tresiba Flextouch U-100Insulin Degludec38$34,582
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$30,430
Spiriva RespimatTiotropium Bromide31$22,708
XareltoRivaroxaban13$21,801
MounjaroTirzepatide19$20,383
TrulicityDulaglutide17$20,076
FarxigaDapagliflozin Propanediol22$18,102
Breo ElliptaFluticasone/Vilanterol23$10,920
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,572
Incruse ElliptaUmeclidinium Bromide14$7,730
Levothyroxine Sodium371$4,708
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$4,544

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$194$86,92354 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$27$57,65284 claims
AbbVieSynthroid$66$3,65571 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 14,618 family providers in Florida.

Other family in Crystal River

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →